Is erythromycin (macrolide antibiotic) safe to use during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Erythromycin Safety in Pregnancy

Erythromycin is safe to use during pregnancy and is classified as FDA Pregnancy Category B, with no evidence of teratogenicity or adverse effects on reproduction in animal studies and human data suggesting low risk if any. 1

FDA Classification and Safety Profile

  • Erythromycin is designated as FDA Pregnancy Category B, meaning animal reproduction studies have failed to demonstrate fetal risk, though adequate well-controlled studies in pregnant humans are lacking 1
  • Animal studies at doses up to 350-700 mg/kg/day (approximately 1-3 times the maximum human dose) showed no evidence of teratogenicity or embryotoxicity in rats, mice, and rabbits 1
  • A large Norwegian population-based registry study of 180,120 pregnancies found no increased risk of cardiovascular malformations (adjusted OR = 1.2 [95% CI 0.8,1.8]) or any other specific malformations with first-trimester erythromycin exposure 2

Clinical Guidelines for Pregnancy Use

  • Erythromycin is recommended as the preferred macrolide for long-term suppression of Bartonella infection during pregnancy, as tetracyclines are contraindicated 3
  • For syphilis treatment in pregnancy, erythromycin is specifically noted as not reliably curing fetal infection and should be avoided; penicillin with desensitization is required instead 4
  • The 2020 ERS/TSANZ guidelines classify erythromycin as "probably safe" during pregnancy (Category A/B), noting that most human reports found no evidence of increased birth defects 5

Important Clinical Caveats

Infantile Hypertrophic Pyloric Stenosis (IHPS)

  • Erythromycin use in newborns carries a risk of IHPS, with a 5% absolute risk in one cohort study (7 of 157 exposed infants) 6, 1
  • The risk appears dose-dependent: 5.1% for 8-14 days of treatment and 10% for 15-21 days 1
  • One epidemiological study suggested a very low risk of pyloric stenosis in infants exposed during the first 13 days of breastfeeding (not after 2 weeks) 5
  • Parents should be counseled to contact their physician if vomiting or irritability with feeding occurs 1

Pharmacokinetic Considerations

  • Serum erythromycin levels are significantly diminished in the third trimester, with delayed absorption and lower peak concentrations compared to non-pregnant patients 7
  • In two pregnant women studied, erythromycin levels were undetectable throughout the 4-hour sampling period, both of whom experienced severe gastrointestinal symptoms 7
  • Severe gastrointestinal adverse events may indicate subtherapeutic plasma concentrations, potentially compromising treatment efficacy 7

Comparative Efficacy in Pregnancy

  • For chlamydial infection in pregnancy, amoxicillin demonstrated superior tolerability with a 2% failure rate versus 12% for erythromycin (p = 0.005) in a randomized controlled trial 8
  • Severe gastrointestinal side-effects occurred in 31% of erythromycin-treated women versus 6% with amoxicillin (p < 0.001) 8
  • Only 1% of amoxicillin-treated women discontinued therapy due to side effects compared to 12% with erythromycin (p = 0.002) 8

Specific Formulation Warning

  • Erythromycin estolate should be avoided during pregnancy due to potential maternal hepatotoxicity 5
  • Other erythromycin formulations (base, stearate, ethylsuccinate) are acceptable 5

Alternative Considerations

  • Azithromycin is the preferred macrolide during pregnancy according to CDC guidelines, with a better safety profile and improved tolerability 9
  • For conditions requiring macrolide therapy in pregnancy, azithromycin should be considered first-line over erythromycin when clinically appropriate 9
  • Penicillins and cephalosporins remain first-line antibiotics during pregnancy when appropriate for the indication 10

Drug Interactions During Pregnancy

  • Erythromycin is a CYP3A4 inhibitor and can increase levels of drugs metabolized by this pathway, including theophylline, digoxin, oral anticoagulants, and certain statins 1
  • Concomitant use with cisapride, pimozide, astemizole, or terfenadine is contraindicated due to risk of QT prolongation and fatal arrhythmias 1

Lactation Considerations

  • Erythromycin is excreted in human milk; caution should be exercised when administered to nursing women 1
  • The very low risk of IHPS in breastfed infants appears limited to the first 13 days of exposure 5

References

Research

Serum erythromycin levels in pregnancy.

Clinical therapeutics, 1998

Guideline

Azithromycin Safety in First Trimester of Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

For a pregnant woman in the first trimester, which of the following antibiotics is preferred: nitrofurantoin (Macrobid), trimethoprim‑sulfamethoxazole (Bactrim), cefepime, gentamicin, levofloxacin (Levaquin), tetracycline, or tobramycin?
What is the recommended dosing of amoxicillin (amoxicillin) for the treatment of chlamydia?
Is amoxicillin (amoxicillin) safe to use during the second trimester of pregnancy?
Is amoxicillin safe to use during pregnancy (all trimesters) and while breastfeeding, and what are the recommended adult dosing regimens?
What are the appropriate oral antibiotic options for chronic suppressive therapy in a patient in the third trimester of pregnancy, including alternatives for penicillin-allergic patients?
What is the comparison between Myrbetriq (mirabegron) and Gemtesa (vibegron) for treating overactive bladder symptoms?
Are there any interactions between melatonin and ondansetron (Zofran) when used together for nausea?
What is the protocol for assessing and managing troponin levels in patients with suspected acute coronary syndrome?
What psych medications are effective for a geriatric Chronic Obstructive Pulmonary Disease (COPD) patient with anxiety exacerbated by shortness of breath?
Should risperidone (Risperdal) be discontinued in a patient with possible dementia who experiences increased confusion, thought blocking, and forgetfulness after starting the medication?
What is the appropriate dosage of Actrapid (human insulin) based on capillary blood glucose (CBG) levels?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.